XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.1
CORRECTION OF AN ERROR IN PREVIOUSLY ISSUED FINANCIAL STATEMENTS
11 Months Ended
Dec. 31, 2020
CORRECTION OF AN ERROR IN PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
CORRECTION OF AN ERROR IN PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2. CORRECTION OF AN ERROR IN PREVIOUSLY ISSUED FINANCIAL STATEMENTS

On April 12, 2021, the Staff of the SEC issued a statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies.” In the statement, the SEC Staff, among other things, highlighted potential accounting implications of certain terms that are common in warrants issued in connection with the initial public offerings of special purpose acquisition companies such as the Company. As a result of the Staff statement and in light of evolving views as to certain provisions commonly included in warrants issued by special purpose acquisition companies, we re-evaluated the accounting for our Warrants and FPA under ASC 815-40, Derivatives and Hedging—Contracts in Entity’s Own Equity, and concluded that they do not meet the criteria to be classified in shareholders’ equity. Since the Warrants and FPA meet the definition of a derivative under ASC 815-40, we have restated the financial statements to classify the Warrants and FPA as liabilities on the balance sheet at fair value, with subsequent changes in their respective fair values recognized in the statement of operations at each reporting date.

The Company's prior accounting treatment for the Warrants and FPA was equity classification rather than as derivative liabilities. Accounting for the Warrants and FPA as liabilities pursuant to ASC 815-40 requires that the Company re-measure the Warrants and FPA to their fair value each reporting period and record the changes in such value in the statement of operations. Accordingly, the Company has restated the value and classification of the Warrants and FPA in our financial statements included herein (“Restatement”).

The following summarizes the effect of the Restatement on each financial statement line item for each period presented herein, each prior interim period of the current fiscal year, and as of the date of the Company’s consummation of its IPO.

 

 

 

 

 

 

 

 

 

    

As of December 31, 2020

 

    

As reported

    

As Restated

    

Difference

Balance Sheet

 

 

 

 

 

 

Warrant liability

 

 —

 

53,005,335

 

53,005,335

FPA Liability

 

 —

 

10,654,540

 

10,654,540

Total Liabilities

 

18,725,550

 

82,385,425

 

63,659,875

Class A ordinary shares subject to possible redemption

 

494,827,880

 

431,168,005

 

(63,659,875)

Class A ordinary shares, $0.0001 par value

 

227

 

863

 

636

Additional paid-in capital

 

5,804,510

 

34,912,594

 

29,108,084

Accumulated deficit

 

(806,028)

 

(29,914,748)

 

(29,108,720)

Total Shareholders’ Equity

 

5,000,003

 

5,000,003

 

 —

 

 

 

 

 

 

 

 

 

 

For the Period from February 11, 2020 through December 31, 2020

 

    

As reported

    

As Restated

    

Difference

Statement of Operations

 

  

 

  

 

  

Change in fair value of warrant liability

 

 —

 

17,328,667

 

17,328,667

Change in fair value of FPA liability

 

 —

 

10,399,002

 

10,399,002

Transaction costs allocated to warrant and FPA liabilities

 

 —

 

1,381,051

 

1,381,051

Net Loss

 

(806,028)

 

(29,914,748)

 

(28,108,720)

Weighted average shares outstanding – redeemable

 

49,551,714

 

45,254,948

 

(4,296,766)

Basic and Diluted EPS – redeemable

 

 —

 

 —

 

 —

Weighted average shares outstanding – non-redeemable

 

13,640,310

 

16,283,431

 

2,643,121

Basic and Diluted EPS – non-redeemable

 

(0.06)

 

(1.84)

 

(1.78)

 

 

 

 

 

 

 

 

 

 

Year Ended 12/31/20

 

    

As reported

    

As Restated

    

Difference

Statement of Changes in Shareholders’ Equity

 

  

 

  

 

  

Class A Ordinary Shares

 

2,267,212

 

8,633,199

 

6,365,987

Class A Ordinary Share Amount

 

227

 

863

 

636

Additional Paid-In capital

 

5,804,510

 

34,912,594

 

29,108,084

Accumulated Deficit

 

(806,028)

 

(29,914,748)

 

(29,108,720)

Total shareholders' equity

 

5,000,003

 

5,000,003

 

 —

 

 

 

 

 

 

 

 

 

 

 

Year Ended 12/31/20

 

 

As reported

 

As Restated

 

Difference

Statement of Cash Flows

    

  

    

 

  

    

  

Net Loss

 

(806,028)

 

 

(29,914,748)

 

(29,108,720)

Change in fair value of warrant liability

 

 —

 

 

17,328,667

 

17,328,667

Change in fair value of FPA liability

 

 —

 

 

10,399,002

 

10,399,002

Transaction costs allocated to warrant and FPA liabilities

 

 —

 

 

1,381,051

 

1,381,051

Initial classification of warrant liability

 

 —

 

 

35,676,668

 

35,676,668

Initial classification of FPA liability

 

 —

 

 

255,538

 

255,538

Initial value of Class A common stock subject to possible redemption

 

495,597,040

 

 

459,696,714

 

(35,900,326)

Change in value of Class A common stock subject to possible redemption

 

(769,160)

 

 

21,426,075

 

22,195,235

 

 

 

 

 

 

 

 

 

 

As of September 30, 2020

 

    

As reported

    

As Restated

    

Difference

Balance Sheet

 

  

 

  

 

  

Warrant liability

 

 —

 

38,225,001

 

38,225,001

FPA Liability

 

 —

 

5,548,575

 

5,548,575

Total Liabilities

 

18,222,551

 

61,996,127

 

43,773,576

Class A ordinary shares subject to possible redemption

 

495,423,880

 

451,650,304

 

(43,773,576)

Class A ordinary shares, $0.0001 par value

 

221

 

658

 

437

Additional paid-in capital

 

5,208,516

 

14,430,500

 

9,221,984

Accumulated deficit

 

(210,021)

 

(9,432,442)

 

(9,222,421)

Total Shareholders’ Equity

 

5,000,010

 

5,000,010

 

 —

 

 

 

 

 

 

 

 

 

 

 

    

For the 3 Months Ended September 30, 2020

 

    

As reported

    

As Restated

    

Difference

Statement of Operations

 

 

  

 

 

  

 

  

Change in fair value of warrant liability

 

 

 —

 

 

(1,529,000)

 

(1,529,000)

Change in fair value of FPA liability

 

 

 —

 

 

2,299,616

 

2,299,616

Transaction costs allocated to warrant and FPA liabilities

 

 

 —

 

 

 —

 

 —

Net Loss

 

 

(173,155)

 

 

(943,771)

 

(770,616)

Weighted average shares outstanding – redeemable

 

 

49,559,704

 

 

45,259,408

 

(4,300,296)

Basic and Diluted EPS – redeemable

 

$

 —

 

$

 —

 

 —

Weighted average shares outstanding – non-redeemable

 

 

15,127,796

 

 

19,428,092

 

4,300,296

Basic and Diluted EPS – non-redeemable

 

$

(0.01)

 

$

(0.05)

 

(0.04)

 

 

 

 

 

 

 

 

 

 

 

    

For the Period from February 11, 2020 through September 30, 2020

 

    

As reported

    

As Restated

    

Difference

Statement of Operations

 

 

  

 

 

  

 

  

Change in fair value of warrant liability

 

 

 —

 

 

2,548,333

 

2,548,333

Change in fair value of FPA liability

 

 

 —

 

 

5,293,037

 

5,293,037

Transaction costs allocated to warrant and FPA liabilities

 

 

 —

 

 

1,381,051

 

1,381,051

Net Loss

 

 

(210,021)

 

 

(9,432,442)

 

(9,222,421)

Weighted average shares outstanding – redeemable

 

 

49,560,044

 

 

45,335,261

 

(4,224,783)

Basic and Diluted EPS – redeemable

 

$

 —

 

$

 —

 

 —

Weighted average shares outstanding – non-redeemable

 

 

13,025,013

 

 

14,959,025

 

1,934,012

Basic and Diluted EPS – non-redeemable

 

$

(0.02)

 

$

(0.63)

 

(0.61)

 

 

 

 

 

 

 

 

 

 

February 11, 2020 (Inception) Through September 30, 2020

 

    

As reported

    

As Restated

    

Difference

Statement of Changes in Shareholders’ Equity

 

  

 

  

 

  

Class A Ordinary Shares

 

2,267,212

 

6,584,969

 

4,317,757

Class A Ordinary Share Amount

 

221

 

658

 

437

Additional Paid-In Capital

 

5,208,516

 

14,430,500

 

9,221,984

Accumulated Deficit

 

(210,021)

 

(9,432,442)

 

(9,222,421)

Total shareholders' equity

 

5,000,010

 

5,000,010

 

 —

 

 

 

 

 

 

 

 

 

 

 

February 11, 2020 (Inception) Through September 30, 2020

 

 

As reported

 

As Restated

 

Difference

Statement of Cash Flows

    

  

    

 

  

    

  

Net Loss

 

(210,021)

 

 

(9,432,442)

 

(9,222,421)

Change in fair value of warrant liability

 

 —

 

 

2,548,333

 

2,548,333

Change in fair value of FPA liability

 

 —

 

 

5,293,037

 

5,293,037

Transaction costs allocated to warrant and FPA liabilities

 

 —

 

 

1,381,051

 

1,381,051

Initial classification of warrant liability

 

 —

 

 

35,676,668

 

35,676,668

Initial classification of FPA liability

 

 —

 

 

255,538

 

255,538

Initial value of Class A common stock subject to possible redemption

 

495,628,920

 

 

459,696,714

 

(35,932,206)

Change in value of Class A common stock subject to possible redemption

 

(205,040)

 

 

(8,046,410)

 

(7,841,370)

 

 

 

 

 

 

 

 

 

 

As of June 30, 2020

 

    

As reported

    

As Restated

    

Difference

Balance Sheet

 

 

 

 

 

 

Warrant liability

 

 —

 

39,754,001

 

39,754,001

FPA Liability

 

 —

 

3,248,959

 

3,248,959

Total Liabilities

 

18,663,985

 

61,666,945

 

43,002,960

Class A ordinary shares subject to possible redemption

 

495,597,040

 

452,594,080

 

(43,002,960)

Class A ordinary shares, $0.0001 par value

 

219

 

649

 

430

Additional paid-in capital

 

5,035,358

 

13,486,733

 

8,451,375

Accumulated deficit

 

(36,866)

 

(8,488,671)

 

(8,451,805)

Total Shareholder's Equity

 

5,000,005

 

5,000,005

 

 —

 

 

 

 

 

 

 

 

 

 

 

 

For the 3 Months Ended June 30, 2020

 

    

As reported

    

As Restated

    

Difference

Statement of Operations

 

 

 

 

 

 

 

 

Change in fair value of warrant liability

 

 

 —

 

 

4,077,333

 

4,077,333

Change in fair value of FPA liability

 

 

 —

 

 

2,993,421

 

2,993,421

Transaction costs allocated to warrant and FPA liabilities

 

 

 —

 

 

1,381,051

 

1,381,051

Net Loss

 

 

(31,882)

 

 

(8,483,687)

 

(8,451,805)

Basic and Diluted EPS – redeemable

 

$

 —

 

$

 —

 

 —

Weighted average shares outstanding – non-redeemable

 

 

11,718,359

 

 

12,152,705

 

434,345

Basic and Diluted EPS – non-redeemable

 

$

 —

 

$

(0.70)

 

(0.70)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Period from February 11, 2020 through June 30, 2020

 

 

 

    

As reported

    

As Restated

    

Difference

 

 

Statement of Operations

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrant liability

 

 

 —

 

 

4,077,333

 

4,077,333

 

 

Change in fair value of FPA liability

 

 

 —

 

 

2,993,421

 

2,993,421

 

 

Transaction costs allocated to warrant and FPA liabilities

 

 

 —

 

 

1,381,051

 

1,381,051

 

 

Net Income (Loss)

 

 

(36,886)

 

 

(8,488,691)

 

(8,451,805)

 

 

Weighted average shares outstanding – redeemable

 

 

49,562,892

 

 

45,969,671

 

(3,593,221)

 

 

Basic and Diluted EPS – redeemable

 

$

 —

 

$

 —

 

 —

 

 

Weighted average shares outstanding – non-redeemable

 

 

11,570,456

 

 

11,867,640

 

297,184

 

 

Basic and Diluted EPS – non-redeemable

 

$

 —

 

$

(0.72)

 

(0.72)

 

 

 

 

 

 

 

 

 

 

 

 

 

February 11, 2020 (Inception) Through June 30, 2020

 

    

As reported

    

As Restated

    

Difference

Statement of Changes in Shareholders’ Equity

 

  

 

  

 

  

Class A Ordinary Shares

 

 2,267,212

 

6,490,592

 

4,223,380

Class A Ordinary Share Amount

 

219

 

649

 

430

Additional Paid-In

 

5,035,358

 

13,486,733

 

8,451,375

Accumulated Deficit

 

(36,866)

 

(8,488,671)

 

(8,451,805)

Total shareholders' equity

 

5,000,005

 

5,000,005

 

 —

 

 

 

 

 

 

 

 

 

 

 

February 11, 2020 (Inception) Through June 30, 2020

 

 

As reported

 

As Restated

 

Difference

Statement of Cash Flows

    

  

    

 

  

    

  

Net Loss

 

(36,866)

 

 

(8,488,671)

 

(8,451,805)

Change in fair value of warrant liability

 

 —

 

 

4,077,333

 

4,077,333

Change in fair value of FPA liability

 

 —

 

 

2,993,421

 

2,993,421

Transaction costs allocated to warrant and FPA liabilities

 

 —

 

 

1,381,051

 

1,381,051

Initial classification of warrant liability

 

 —

 

 

35,676,668

 

35,676,668

Initial classification of FPA liability

 

 —

 

 

255,538

 

255,538

Initial value of Class A common stock subject to possible redemption

 

495,628,920

 

 

459,696,714

 

(35,932,206)

Change in value of Class A common stock subject to possible redemption

 

(31,880)

 

 

(7,102,634)

 

(7,070,754)

 

 

 

 

 

 

 

 

 

 

As of June 19, 2020

 

    

As reported

    

As Restated

    

Difference

Balance Sheet

 

  

 

  

 

  

Warrant liability

 

 —

 

35,676,668

 

35,676,668

FPA Liability

 

 —

 

255,538

 

255,538

Total Liabilities

 

18,892,430

 

54,824,636

 

35,932,206

Class A ordinary shares subject to possible redemption

 

495,597,920

 

459,696,714

 

(35,932,206)

Class A ordinary shares, $0.0001 par value

 

219

 

578

 

359

Additional paid-in capital

 

5,003,478

 

6,384,170

 

1,380,692

Accumulated deficit

 

(4,983)

 

(1,381,051)

 

(1,386,034)

Total Shareholder's Equity

 

5,000,008

 

5,000,008

 

 —